Position in IBRX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$4,175,565
+$1,398,604 QoQ
Shares Held
476,935
+31.7% QoQ
Ownership
0.045%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#49
of 403 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 22%
Shared 0%
None 78%
Common Shares in IBRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. IBRX ranks #59 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in IBRX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,175,565 | 476,935 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $2,776,961 | 362,055 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $648,651 | 327,602 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $773,972 | 314,623 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $883,230 | 334,557 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $660,273 | 219,360 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $531,934 | 207,787 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $771,855 | 207,488 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,337,798 | 211,677 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $1,003,518 | 186,875 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $897,776 | 178,840 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $239,633 | 141,795 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $409,063 | 147,145 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $203,428 | 111,774 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $570,902 | 112,604 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $544,349 | 109,527 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $375,839 | 101,032 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $494,370 | 88,123 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $548,890 | 90,278 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $900,053 | 92,408 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,272,919 | 89,140 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $899,532 | 37,891 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 NK | — | 40,328 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 NK | — | 37,158 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 NK | — | 36,899 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||